PHX.AX · PHARMX TECHNOLOGIES LIMITED
Australia · RS rating 26 · As of 2026-10-14
| Price | 0.08 AUD |
|---|---|
| 1-day change | -1.2% |
| RS rating (overall / 1M / 3M / 12M) | 26 / 56 / 16 / 40 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 25 / 14 / 19 |
| Industry group (rank) | Medical-Biomed/Biotech (–) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | – |
| Distance from 52-week high | +51.2% |
| Market cap (USD) | $41.4M |